Our passion for improving patients’ lives motivates us to apply our skills, experience, and knowledge to advance medicine. We achieve this through flexible, innovative, high-quality solutions for our clients, delivered with integrity. Simbec-Orion is uniquely positioned as a global, full-service CRO, delivering a full suite of clinical trial designs from First-in-Human to Phase III and post-marketing, including comprehensive, fully integrated support services. Over nearly 5 decades, we have built wide therapeutic experience and specialist expertise in clinical pharmacology, oncology, and rare diseases. Structured to adapt quickly, we provide full-service clinical development solutions for small and mid-size drug developers. With a focus on tailor-made and scalable solutions, we’ll match our delivery style, communications, and operations to suit the demands of your project, helping you achieve your clinical and commercial objectives. Because our goal is the same as yours; to accelerate improved medicines for patients in need.
Looking for a particular Simbec-Orion employee's phone or email?
The Simbec-Orion annual revenue was $97.2 million in 2026.
Aize Smink is the COO of Simbec-Orion.
248 people are employed at Simbec-Orion.
Simbec-Orion is based in Merthyr Tydfil, Wales.